Global Innovative Platforms (GIPL) FCF Margin (2025 - 2026)

Global Innovative Platforms' (GIPL) quarterly FCF Margin came in at 372.15% in Q2 2026, down 155.34% quarter-over-quarter from 672.46% in Q1 2026.

Analysis

Global Innovative Platforms (GIPL) FCF Margin (2025 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed FCF Margin across 2 years of filings, most recently posting 372.15% for Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Idexx Laboratories	40.69 Bn	40.49 Bn	779.09 Mn	26.51%
2	Zoetis	30.63 Bn	28.95 Bn	1.05 Bn	21.80%
3	Elanco Animal Health	11.77 Bn	11.24 Bn	798.00 Mn	17.84%
4	Phibro Animal Health	1.49 Bn	1.41 Bn	134.40 Mn	1.32%
5	Immucell	90.19 Mn	81.33 Mn	2.44 Mn	-
6	Zhengye Biotechnology Holding	76.23 Mn	69.14 Mn	-	-
7	Global Innovative Platforms	24.88 Mn	24.63 Mn	-	-372.15%

Historic Data

Download Data